EYPT EPS Estimates
EyePoint Pharmaceuticals, Inc.
$3.01
-$0.06(-1.95%)
31
Overall
40
Value
18
Tech
36
Quality
Market Cap
$259.50M
Volume
3.16M
52W Range
$3.05 - $19.11
Target Price
$26.10
EYPT EPS estimates: the consensus estimate for EyePoint Pharmaceuticals, Inc.'s current fiscal year is -$3.51 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
EYPT EPS Estimates
- EPS estimate, current quarter
- $-0.81
- EPS estimate, next quarter
- $-0.66
- EPS estimate, current year
- $-3.51
- EPS estimate, next year
- $-2.36
- EPS growth, 3-year
- -4.98%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.17 |
| 2024 | $-2.32 |
| 2023 | $-1.82 |
| 2022 | $-2.74 |
| 2021 | $-2.03 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EYPT | $3.01 | -2.0% | 3.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get EyePoint Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW